UiPath Inc (NYSE: PATH) stock declined on weak Q4 revenue and Q1 guidance. Needham analyst reiterated Hold. Deal delays and uncertainty in US Fed segment.
Latest Ratings for PATH
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2022 | Macquarie | Upgrades | Neutral | Outperform |
| Jan 2022 | Macquarie | Upgrades | Neutral | Outperform |
| Jan 2022 | Oppenheimer | Upgrades | Perform | Outperform |
